Company intelligence / Profile preview

AbelaPharm

Belgrade, Serbia

Ownership: Private
Employees: ~350
Development stage: Other

Overview

AbelaPharm is a leading regional pharmaceutical company based in Serbia, specializing in the development, production, and distribution of high-quality drugs, dietary supplements, and medical devices. The company is particularly recognized for its expertise in gastroenterology, respiratory health, and the production of probiotics using innovative flow-pack technology to ensure stability.

Therapeutic areas: EndocrinologyInfectious DiseasesRheumatologyPulmonologyGastroenterologyPsychiatry
Modalities: Small moleculeLive biotherapeutic product therapyProteinPeptides
Industry: Biotech

Partnerships

AlvogenLallemand Health Solutions

Beyond the preview

Go deeper on AbelaPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AbelaPharm.

Explore the full profile